Michael Gelband’s Terns Pharmaceuticals TERN Stock Holding History

Michael Gelband’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-153,400	Closed	-$8.09M	–	2058
2026 Q1	$8.09M	Buy	+153,400	New	+$6.3M	0.06%	286

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Michael Gelband's TERN Position: Q2 2026 in Review

Michael Gelband sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 80,245 shares — an estimated $4.23M sold.

Michael Gelband first reported a position in TERN in Q4 2023 and held it in 6 quarters. The position peaked at $15.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Michael Gelband reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 80,245 Terns Pharmaceuticals shares in Q2 2026, an estimated $4.23M.
Michael Gelband first reported a position in Terns Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Michael Gelband's Terns Pharmaceuticals position peaked at $15.2M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.